2019 THRIVE Grant Award Winners

Munjal Acharya potrait

HESI THRIVE Research Study: Targeting complement signaling to ameliorate cranial radiation-induced brain injury

Kate Hutchenson Photo

HESI THRIVE Research Study: Stop LCNP: High dose steroid therapy for late radiation-associated lower cranial neuropathy

  • Dr. Kate Hutchenson, Professor
  • Department of Head and Neck Surgery/University of Texas MD Anderson Cancer Center
Sokol Elizabeth

HESI THRIVE Research Study: Utilization of a Pharmacogenomics approach to decrease incidence of vincristine associated peripheral neuropathy in pediatric oncology patients

  • Dr. Elizabeth Sokol, Attending Physician
  • Hematology/Oncology Assistant Professor of Pediatrics Ann & Robert Lurie Children’s Hospital of Chicago

HESI THRIVE Research Study: FMT treatment for immune checkpoint inhibitor-mediated colitis

  • Dr. Yinghong Wang, Gastroenterologist
  • Department of Gastroenterology Hepatology and Nutrition,University of Texas MD Anderson Cancer Center

By providing researchers with both seed funding and access to critical networks, THRIVE will enhance the visibility of the patient need, the value of the research, and the reasons that larger funding entities might elect to incorporate these research streams into future funding priorities. Click here to learn more about grant guidelines, the application process, and selection process.